Sources | Names Used |
---|---|
GDSC1000 | MPS-1-IN-1 |
PharmacoGx | MPS-1-IN-1 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NSF | GDSC1000 | pan-cancer | AAC | -0.081 | 0.01 |
mRNA | PHF21B | GDSC1000 | pan-cancer | AAC | 0.088 | 0.01 |
mRNA | TMED5 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.01 |
mRNA | POLR1D | GDSC1000 | pan-cancer | AAC | 0.089 | 0.01 |
mRNA | TMEM181 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |
mRNA | HLA-F | GDSC1000 | pan-cancer | AAC | -0.082 | 0.01 |
mRNA | CCDC8 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |
mRNA | ZNF41 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.01 |
mRNA | CLSTN2 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |
mRNA | STX4 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.01 |